NCT03400358

Brief Summary

To evaluate the uterocervical angle (UCA) in the prediction of second trimester termination success of multiparous women.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
148

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2017

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2017

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

January 6, 2018

Completed
11 days until next milestone

First Posted

Study publicly available on registry

January 17, 2018

Completed
14 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2018

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2018

Completed
Last Updated

March 6, 2018

Status Verified

March 1, 2018

Enrollment Period

4 months

First QC Date

January 6, 2018

Last Update Submit

March 3, 2018

Conditions

Keywords

uterocervical anglemultiparous

Outcome Measures

Primary Outcomes (1)

  • uterocervical angle

    the angle between the cervical canal and anterior uterine wall

    1 week

Study Arms (1)

Medical abortion

150 singleton multiparous patients are planning to complete the study period. Study group constitute of second trimester pregnancies between 14-24 weeks of gestation. All participants were multiparous and had no systemic illnesses. The uterocervical angle will be measured in all participants before the induction of labor.

Other: uterocervical angle

Interventions

the angle between cervical canal and anterior uterine wall is measured sonographically.

Medical abortion

Eligibility Criteria

Age20 Years - 40 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Multiparous pregnant women undergoing medical abortion in the second trimester

You may qualify if:

  • multiparous singleton pregnancy
  • no previous systemic illnesses

You may not qualify if:

  • abnormal Pap smear
  • history of dilatation and curettage (D\&C)
  • history of LEEP and cervical conization

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kanuni SSTRH

Istanbul, Turkey (Türkiye)

Location

Related Links

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Md, ObGYN

Study Record Dates

First Submitted

January 6, 2018

First Posted

January 17, 2018

Study Start

October 1, 2017

Primary Completion

January 31, 2018

Study Completion

February 1, 2018

Last Updated

March 6, 2018

Record last verified: 2018-03

Data Sharing

IPD Sharing
Will not share

Locations